Cervical Artery Dissection
6
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Defining the Basis of Fibromuscular Dysplasia (FMD)
Risk of Recurrent CeAD After Pregnancy
Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD
Risk of Recurrence of Cervical Artery Dissection During Pregnancy and Puerperium
To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections